miRNAs significantly differentially expressed in post-treatment high-risk cases [Post-HR] when compared to post-treatment intermediate-risk cases [Post-IR-NBl].

<p>miRNAs significantly differentially expressed in post-treatment high-risk cases [Post-HR] when compared to post-treatment intermediate-risk cases [Post-IR-NBl].</p

miRNAs significantly up-regulated within the blastemal component of post-treatment high risk cases [Post-HR] when compared to post-treatment intermediate risk cases [Post-IR-Bl].

<p>miRNAs significantly up-regulated within the blastemal component of post-treatment high risk cases [Post-HR] when compared to post-treatment intermediate risk cases [Post-IR-Bl].</p

Sample Cohort.

<p>Sample Cohort.</p

miRNAs significantly differentially expressed in both pre-treatment high risk group [Pre-HR] compared to pre-treatment intermediate risk group [Pre-IR], and also in the post-treatment high-risk group [Post-HR] compared to the post-treatment intermediate risk group [Post-IR-NBl].

<p>miRNAs significantly differentially expressed in both pre-treatment high risk group [Pre-HR] compared to pre-treatment intermediate risk group [Pre-IR], and also in the post-treatment high-risk group [Post-HR] compared to the post-treatment intermediate risk group [Post-IR-NBl].</p